Impact of phosphate binder type on coronary artery calcification in hemodialysis patients

R Shantouf1, N Ahmadi, F Flores

  • 1Division of Cardiology, Los Angeles Biomedical Research Institute at Harbor-UCLA, Torrance, CA, USA.

Clinical Nephrology
|June 19, 2010
PubMed

Insights

Calcium-free sevelamer use in maintenance hemodialysis patients was associated with lower coronary artery calcification (CAC) compared to calcium-based phosphate binders (CBPB). This finding suggests sevelamer may be a safer option for managing phosphate levels and cardiovascular risk in CKD patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Coronary artery calcification (CAC) is highly prevalent in chronic kidney disease (CKD) patients, particularly those on maintenance hemodialysis (MHD).
  • Phosphate binders are crucial for managing hyperphosphatemia in CKD, but their impact on cardiovascular calcification varies.
  • Calcium-based phosphate binders (CBPB) have been linked to increased calcification, prompting research into alternatives like calcium-free binders.

Purpose of the Study:

  • To investigate the association between sevelamer (a calcium-free phosphate binder) and coronary artery calcification (CAC) in MHD patients.
  • To compare CAC scores in MHD patients treated with sevelamer versus those treated with CBPB.
  • To determine if sevelamer monotherapy is associated with reduced CAC compared to CBPB monotherapy in MHD patients.

Main Methods:

  • A cross-sectional study involving 117 maintenance hemodialysis (MHD) patients.
  • Patients were categorized into two groups: those taking only CBPB (n=60) and those taking only sevelamer (n=57).
  • Coronary artery calcium scores (CACS) were assessed using computerized tomography; logistic regression analyzed the odds of significant CAC.

Main Results:

  • Despite a higher prevalence of diabetes mellitus (DM) in the sevelamer group (58% vs. 35%), CACS was significantly lower in sevelamer users (283 ± 83) compared to CBPB users (494 ± 94; p=0.02).
  • After adjusting for covariates, CBPB use was associated with significantly higher odds of severe CAC (CACS ≥ 400) compared to sevelamer use (OR=4.35; 95% CI: 1.5-9.9; p=0.008).

Conclusions:

  • Significant coronary artery calcification (CAC) is more prevalent in maintenance hemodialysis (MHD) patients treated with calcium-based phosphate binders (CBPB) compared to those on sevelamer monotherapy.
  • These findings suggest that calcium-free phosphate binders like sevelamer may play a role in mitigating cardiovascular calcification in MHD patients.
  • Further prospective studies are warranted to confirm the cardiovascular benefits of sevelamer in this high-risk population.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily regulated...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...